Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study.

@article{Crommentuyn2005TherapeuticDM,
  title={Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study.},
  author={Kristel M L Crommentuyn and Alwin D. R. Huitema and Kees Brinkman and Marchina Elisabeth van der Ende and Frank de Wolf and Jos H. Beijnen},
  journal={Journal of acquired immune deficiency syndromes},
  year={2005},
  volume={39 2},
  pages={249-50}
}